Michael J. Valentino, President & CEO at Adams Respiratory Therapeutics, Inc. (ARXT), sold 70,000 shares at $59.65 ($4.2M) on 2008-01-02, disclosed to the SEC on 2008-01-03.
Scheduled sale ($4.2M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.64 | 12,300 | $734K | 17.6% |
| 2 | $59.65 | 33,375 | $2.0M | 47.7% |
| 3 | $59.66 | 10,081 | $601K | 14.4% |
| 4 | $59.67 | 8,012 | $478K | 11.4% |
| 5 | $59.68 | 4,800 | $286K | 6.9% |
| 6 | $59.69 | 700 |
| $42K |
| 1.0% |
| 7 | $59.70 | 700 | $42K | 1.0% |
| 8 | $59.71 | 32 | $2K | 0.0% |
| Total | $59.65 avg | 70,000 | $4.2M | 100% |
| Filing → |
| PLXP | BUY | 2020-11-20 | $1.0M | — | Filing → |
| PLXP | BUY | 2019-05-21 | $497K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $400K | — | Filing → |